Article

Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study

2024-01-04

Abstract excerpt

<title>Abstract</title> <p>Background To analyze the economic benefits of paliperidone palmitate in the treatment of schizophrenia. Methods We collected 546 patients who met the diagnostic criteria for schizophrenia according to the 《International Statistical Classification of Diseases and Related Health Problems,10th》(ICD-10). We gathered general population data such as gender, age, marital status, and educati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a3ccbd3-133b-5c22-87f3-f4c1cd9a1650
DOI: 10.21203/rs.3.rs-3820566/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studyDOI 10.21203/rs.3.rs-3820566/v1Read

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness studySemantic proximity Read

The Global Economic Burden of Schizophrenia: An Umbrella Review of Systematic Reviews and Meta-AnalysesSemantic proximity Read

Long-term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults with Schizophrenia: Pooled Post hoc Analyses of Two 12-month Extension StudiesSemantic proximity Read

“The Efficacy and Safety of Aripiprazole and Paliperidone 1 and 3-Month Long-Acting Preparations During The Maintenance of Schizophrenia in Clinical Practice”Semantic proximity Read

Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm studySemantic proximity Read

Long-term Metabolic Side Effects of Second-Generation Antipsychotics in Chinese Patients with Schizophrenia: A Within-Subject Approach with modelling of dosage effectsSemantic proximity Read

Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and DiscontinuationSemantic proximity Read

Nonmedical Interventions for Schizophrenia: A Review of Diet, Exercise and Social RolesSemantic proximity Read

Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimationSemantic proximity Read

Prevalence and associated factors of Tardive dyskinesia among psychiatric patients on first-generation antipsychotics at Jimma University specialized hospital, psychiatric clinic, Ethiopia: Institution based a cross-sectional studySemantic proximity Read

Understanding the direct and indirect costs of patients with schizophreniaSemantic proximity Read

Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity Read